/People

Claire Leurent

Investor

Managing Director at AbbVie

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Claire

959 people in our graph can introduce you to Claire.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Kobe to introduce you to Claire

You →Kobe · together at Johnson & Johnson (2019–2020) →Claire

Ask Jamie Chen to introduce you to Claire

You →Jamie · 10 people · together at Johnson & Johnson →Claire

Ask Sam Okafor to introduce you to Claire

You →Sam · together at Vor Biopharma →Claire

Sign up to find every way you can get introduced to Claire

  • Your email: the people you already email who know Claire
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Claire
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Claire Leurent pairs drug-development experience at Pfizer and Wyeth with cross-institutional venture investing at Samsung, J&J and the NIH, and—while teaching strategy at Northeastern—creates custom deal structures across stages.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtech

Experience

  1. AbbVie VenturesManaging Directorcurrent2024 — present
  2. The National Institutes of HealthEntrepreneur in Residence2023 — 2024Bethesda, Maryland, United States
  3. Johnson & JohnsonPrincipal, Venture Investments @ JJDC2019 — 2023
  4. Locus Biosciences, Inc.Board Observer2022
  5. POINT BiopharmaInvestor2021 — 2022
  6. PaigeInvestor2021 — 2022New York City Metropolitan Area
  7. CuraSen Therapeutics, Inc.Board Observer2020 — 2022
  8. X-Vax Technology, Inc.Board Observer2020 — 2022
  9. Vor BiopharmaBoard Observer2019 — 2020
  10. Samsung Venture InvestmentManaging Director2018 — 2019Greater Boston Area
  11. Samsung Venture InvestmentBio Sector Investment Director - Samsung Ventures America2017 — 2019
  12. Digital AssetInvestor2019
  13. Adicet Bio, IncInvestor2019
  14. WelldocBoard Observer2019
  15. Pillo HealthBoard Observer2019Boston, Massachusetts
  16. PfizerDirector - Neuroscience Clinical Research2010 — 2017Cambridge, Massachusetts
  17. PfizerSenior Clinical Scientist2004 — 2010
  18. Forenap PharmaProject Manager2003 — 2004
  19. IGBMC - Institut de Génétique et de Biologie Moléculaire - Strasbourg-Illkirch/FrancePhD1999 — 2003

Skills & more

Neuroscience99Pharmaceutical Industry99Clinical Research99Life Sciences98Biotechnology83Clinical Development82Drug Development74Clinical Trials63Drug Discovery51Pharmacology34Molecular Biology29Lifesciences24
+12 moreGCPOncologyRegulatory AffairsBusiness DevelopmentRegulatory SubmissionsTherapeutic AreasImmunologyFDANeurologyMentoringINDVaccines

From Claire's professional profile.

Colleagues at AbbVie

Frequently asked questions

Who is Claire Leurent?
Claire Leurent pairs drug-development experience at Pfizer and Wyeth with cross-institutional venture investing at Samsung, J&J and the NIH, and—while teaching strategy at Northeastern—creates custom deal structures across stages.
Where does Claire Leurent work?
Claire Leurent is Managing Director at AbbVie.
What does Claire Leurent invest in?
Claire Leurent invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
What check size does Claire Leurent write?
Claire Leurent typically writes checks of $100K – $5M.
Where did Claire Leurent go to school?
Claire Leurent studied at MIT Sloan School of Management (Master of Business Administration (MBA), Business Administration and Management); Pierre and Marie Curie University (Certification in CNS Pharmacology); Université Louis Pasteur (Strasbourg I) (PhD, Molecular and Cellular Biology).

Same school

Shared employers